Case report reveals a rare triple-component lung cancer diagnosed after failed initial biopsy, emphasizing diagnostic awareness.
Combined lung carcinomas containing both non-small cell and high-grade neuroendocrine components are rare and diagnostically challenging due to intratumoral heterogeneity. We report a 61-year-old never-smoking woman with pleuritic chest discomfort and chronic cough. Computed tomography (CT) and positron emission tomography (PET)/CT demonstrated a left upper-lobe pulmonary nodule with intensely FDG-avid hilar and mediastinal lymphadenopathy. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of FDG-avid lymph nodes was nondiagnostic. Given persistent clinical and radiologic concern for malignancy, the patient underwent video-assisted thoracoscopic surgery (VATS) for definitive diagnosis. Pathology revealed a rare triple-component malignancy composed of adenocarcinoma, large-cell neuroendocrine carcinoma, and small-cell lung carcinoma, with metastatic neuroendocrine carcinoma involving mediastinal lymph nodes and pleura, consistent with stage IVA disease. The patient was subsequently treated with platinum-etoposide-based systemic therapy, with immunotherapy planned as part of her treatment course. This case highlights that nondiagnostic minimally invasive sampling does not exclude malignancy and underscores the importance of radiologic-pathologic concordance, awareness of sampling limitations, and timely escalation to additional tissue acquisition, including surgical biopsy when appropriate.
No takes yet. Share an insight, caveat, or question.
Le et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: